Skip to main content

Want a detailed portfolio tracker?

Adaptimmune Therapeutics plc American Depositary Shares (ADAP) P/E (2015 - 2025)

Adaptimmune Therapeutics plc American Depositary Shares (ADAP) P/E from Jun 30, 2015 to Oct 27, 2025. The TTM Adaptimmune Therapeutics plc American Depositary Shares (ADAP) P/E is -0.50. You can export chart.

P/E

Annual P/E change of Adaptimmune Therapeutics plc American Depositary Shares (ADAP)

YearP/EChange
2025-0.50-95.45%
2024-10.92+13.03%
2023-9.66+21.42%
2022-7.96-64.10%
2021-22.16-36.10%
2020-34.68+529.65%
2019-5.51-83.86%
2018-34.12-36.19%
2017-53.47+100.61%
2016-26.65-85.47%
2015-183.46N/A

Comparison Adaptimmune Therapeutics plc American Depositary Shares (ADAP) P/E with competitors

Adaptimmune Therapeutics plc American Depositary Shares (ADAP) P/E is -0.50.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.34%
NBYStablecoin Development Corp0.10-120.58%
ENLVEnlivex Therapeutics Ltd0.15-130.23%
FGENFibroGen Inc0.24-148.31%
TRAWTraws Pharma Inc0.47-195.17%
FBIOFortress Biotech Inc0.71-242.11%
CHRSCoherus Biosciences Inc0.98-296.87%
ORMPOramed Pharmaceuticals Inc1.47-396.57%
AGENAgenus Inc2.05-512.31%
VIVSVivoSim Labs Inc2.54-610.39%
INVAInnoviva Inc3.19-741.77%
CRMDCorMedix Inc3.65-833.80%
ABEOAbeona Therapeutics Inc4.20-946.37%
VXRTVaxart Inc4.26-957.77%
CVACCureVac N.V.4.45-994.80%
SRPTSarepta Therapeutics Inc4.62-1030.75%
GLPGGalapagos NV4.86-1077.97%
RIGLRigel Pharmaceuticals4.92-1090.19%
ZVRAZevra Therapeutics Inc4.97-1101.16%
ABUSArbutus Biopharma Corp5.69-1246.02%
CGENCompugen Ltd7.38-1586.23%
AUPHAurinia Pharmaceuticals Inc9.25-1962.13%
ACADAcadia Pharmaceuticals Inc9.59-2029.88%
OMEROmeros Corporation9.88-2089.34%
PLXProtalix BioTherapeutics Inc9.91-2094.51%
SPROSpero Therapeutics Inc10.73-2260.69%
ADMAAdma Biologics Inc11.33-2380.63%
SVASinovac Biotech Ltd11.44-2401.85%
TBPHTheravance Biopharma Inc11.78-2470.41%
HRMYHarmony Biosciences Holdings Inc12.18-2551.68%
TGTXTG Therapeutics Inc13.18-2752.77%
INCYIncyte Corp13.38-2793.55%
SABSSAB Biotherapeutics Inc14.06-2929.55%
XOMAXOMA Corp14.95-3108.19%
REGNRegeneron Pharmaceuticals Inc14.98-3115.24%
PBYIPuma Biotechnology Inc15.05-3129.37%
EXELExelixis Inc15.79-3279.20%
NAGENiagen Bioscience Inc16.35-3391.94%
CPRXCatalyst Pharmaceuticals Inc17.34-3591.17%
MDXGMimedx Group Inc17.38-3597.33%
ARGXArgen X SE23.07-4743.88%
HALOHalozyme Therapeutics Inc23.20-4769.84%
XOMAOXOMA Corp25.34-5201.43%
VRTXVertex Pharmaceuticals Inc25.66-5264.03%
XOMAPXOMA Corp25.67-5266.91%
CTMXCytomX Therapeutics Inc25.70-5272.50%
ASNDAscendis Pharma A/S26.35-5404.59%
RPRXRoyalty Pharma plc - Class A27.50-5634.31%
SLNOSoleno Therapeutics Inc29.02-5940.24%
LGNDLigand Pharmaceuticals Inc - Class B30.19-6175.98%
BMRNBiomarin Pharmaceutical Inc37.51-7649.51%
APLSApellis Pharmaceuticals Inc39.02-7954.24%
KRYSKrystal Biotech Inc39.70-8090.38%
GMABGenmab40.20-8192.23%
ONCBeiGene Ltd67.03-13591.28%
TECHBio-Techne Corp68.59-13906.91%
VCELVericel Corp80.63-16329.17%
PHARPharming Group N.V.87.74-17760.47%
ALNYAlnylam Pharmaceuticals Inc124.93-25246.84%
TLXTelix Pharmaceuticals Ltd139.89-28257.41%
CORTCorcept Therapeutics Inc158.39-31980.84%